AstraZeneca plans to build $1.5 billion manufacturing facility in Singapore
(Reuters) -AstraZeneca said on Monday it plans to build a $1.5 billion manufacturing facility in Singapore in an effort to en...
May 20, 2024
Genetic profile may predict best response to weight-loss drug Wegovy
By Nancy Lapid (Reuters) - Certain genes may identify patients with obesity who are most likely to respond strongly to Novo N...
May 20, 2024
US race-neutral lung assessments to have profound effects, study finds
By Nancy Lapid (Reuters) - A guideline for U.S. doctors to ignore race in assessing lung health will likely have profound eff...
May 19, 2024
Bird flu found in western China as US combats cattle outbreak
BEIJING (Reuters) - Cases of bird flu have been confirmed among wild fowl in western China, the agriculture ministry said on ...
May 18, 2024
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
By Blake Brittain (Reuters) - AstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after...
May 17, 2024
J&J-backed startup Rapport files for US IPO
(Reuters) - Biopharmaceutical company Rapport Therapeutics, backed by the venture capital arm of Johnson & Johnson, filed...
May 17, 2024
Ontario reports first death from measles in over a decade
TORONTO, (Reuters) - An Ontario child under the age of five has died of measles making it the first such case in more than a ...
May 17, 2024
Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot
(Reuters) -Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its COVID-19 vac...
May 17, 2024
EU regulator scraps approval for pregnancy drug over cancer risk
(Reuters) - The European Medicines Agency (EMA) on Friday recommended scrapping approval for a drug used to prolong gestation...
May 17, 2024
Investors demand clarity from Fresenius over dialysis group FMC
FRANKFURT (Reuters) - Investors demanded more clarity from German healthcare group Fresenius SE on Friday regarding its plans...
May 17, 2024